Cite
CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome
MLA
Koumpis, Epameinondas Tassi, Iliana Malea, Theodora and Papathanasiou, Konstantina Papakonstantinou, Ioannis Serpanou, Anastasia Tsolas, Evangelos Kapsali, Eleni Vassilakopoulos, Theodoros P.Papoudou-Bai, Alexandra Hatzimichael, Eleftheria. CD56 Expression in Multiple Myeloma: Correlation with Poor Prognostic Markers but No Effect on Outcome. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..1d9ab8cdc9e79bbf628ca6134ada4b6d&authtype=sso&custid=ns315887.
APA
Koumpis, E. T. I. M. T. and P. K. P. I. S. A. T. E. K. E. V. T. P. P.-B. A. H. E. (2021). CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome.
Chicago
Koumpis, Epameinondas Tassi, Iliana Malea, Theodora and Papathanasiou, Konstantina Papakonstantinou, Ioannis Serpanou, Anastasia Tsolas, Evangelos Kapsali, Eleni Vassilakopoulos, Theodoros P. Papoudou-Bai, Alexandra Hatzimichael, Eleftheria. 2021. “CD56 Expression in Multiple Myeloma: Correlation with Poor Prognostic Markers but No Effect on Outcome,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..1d9ab8cdc9e79bbf628ca6134ada4b6d&authtype=sso&custid=ns315887.